11/6/2024  5:29:50 PM Chg. -42.80 Volume Bid5:30:00 PM Ask5:30:00 PM Market Capitalization Dividend Y. P/E Ratio
929.20GBX -4.40% 1.37 mill.
Turnover(GBP): 12.76 mill.
-Bid Size: - -Ask Size: - 8.11 bill.GBP - -

Business description

Smith & Nephew plc is a global medical technology business. The company has two reportable business segments: Advanced Surgical Devices (Orthopaedic Reconstruction, Trauma & Extremities, Sports Medicine and Arthroscopy Enabling Technologies) and Advanced Wound Management. Smith & Nephew has a track record of bringing innovative new products to market that provide better clinical outcomes for patients and save costs for healthcare providers. The company has distribution channels, purchasing agents and buying entities in over 100 countries worldwide. Smith & Nephew plc is headquartered in London, UK.
 

Management board & Supervisory board

CEO
Deepak Nath
Management board
John Rogers, Paul Connolly, Phil Cowdy, Mizanu Kebede, Elga Lohler, Vasant Padmanabhan, Alison Parkes, Helen Barraclough, Scott Schaffner, Rohit Kashyap, Craig Gaffin
Supervisory board
Rupert Soames, Deepak Nath, Marc Owen, Jo Hallas, John Ma, Angie Risley, Bob White, Katarzyna Mazur-Hofsaess, John Rogers, Simon Lowth, Jez Maiden
 

Company data

Name: Smith & Nephew plc
Address: Building 5, Croxley Park Hatters Lane Watford,Hertfordshire WD18 8YE UK
Phone: +44-1923-477-100
Fax: -
E-mail: -
Internet: www.smith-nephew.com/
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: -
IPO date: -

Investor relations

Name: Andrew Swift
IR phone: +44-117-378-5450
IR Fax: -
IR e-mail: Investorrelations.gl...hew.com Investorrelations.global@smith-nephew.com

Main Shareholders

Others
 
94.80%
BlackRock, Inc.
 
5.20%